SAOB-0401

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSAOB-0401
Drug Alias NameXenavexoleander extract (ShimodaAtlantic)SAOB-0401
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionTranscription factor AP1 inhibitorsNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complexTranscription factor AP1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShimodaAtlantic Oncology Biosciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShimodaAtlantic Oncology Biosciences LLC
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A